PropertyValue
?:abstract
  • From the Document: Since the beginning of the COVID-19 [coronavirus disease 2019] pandemic, the FDA has been working to facilitate development and availability of therapeutics for use by patients, physicians and health systems as expeditiously and safely as possible In order to facilitate the development of potential COVID-19 treatments FDA created the Coronavirus Treatment Acceleration Program (CTAP), a new program designed to expedite the development of potential COVID-19 therapies by using every tool at the agency\'s disposal to determine if the therapies are safe and effective for their intended uses Several therapies are currently being tested in clinical trials to evaluate whether they are safe and effective in combating COVID-19 COVID-19 (Disease);United States Food and Drug Administration;Epidemics
?:creator
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • FDA Combating COVID-19 with Therapeutics
?:type
?:who_covidence_id
  • #740841
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/3i0linum>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/3i0linum>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all